Venetoclax | compare suppliers & send inquiries for free
Looking for Venetoclax 1257044-40-8?
Why are people looking for Venetoclax? Venetoclax is a BCL-2 inhibitor that was initially approved by the FDA in April 2016. Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are important regulators of the apoptotic (programmed cell death) process 1,. Venetoclax is used to treat chronic lymphocytic leukemia (CLL) and certain types of small lymphocytic lymphoma. CLL is the most prevalent leukemia diagnosed in Western countries.
Venetoclax was developed through reverse engineering of the BCL-2 protein family inhibitor, navitoclax. Venetoclax is approximately 10 times more potent than navitoclax with regard to induction of apoptosis in CLL cells. A new indication was approved in 2018 for the treatment patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without 17p deletion, who have received at least one prior therapy. Previously, this drug was indicated only for patients with 17p gene deletion.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Venetoclax manufacturers | traders | suppliers
We have 4 companies offering Venetoclax from 2 different countries.
Get in contact with the supplier of your choice:
- JINLAN Pharm-Drugs Technology Co., Ltd. from China
- LEBSA from Spain
- Shandong Octagon Chemicals Limited from China
- Suzhou Bichal Biological Technology from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.